A Phase 2 Study to Assess STP938 (Dencatistat) as a Monotherapy in Adults With High Risk Essential Thrombocythaemia - The VECTRA Trial
A Phase 2 Study to Assess STP938 (Dencatistat) as a Monotherapy in Adults With High Risk Essential Thrombocythaemia - The VECTRA Trial
Recruiting · NCT06786234 · Registry updated 2026-06-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 2 Study to Assess STP938 (Dencatistat) as a Monotherapy in Adults With High Risk Essential Thrombocythaemia - The VECTRA Trial | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, blood coagulation disease, blood platelet disease, bone marrow disorder, essential thrombocythemia, hematologic disorder, hemorrhagic disease, thrombocytosis disease | Recruiting | Phase 2 | 2026-06-16 | NCT06786234 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Step Pharma, SAS | 3 |
14 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cancer and Haematology Centre, Churchill Hospital | Oxford | United Kingdom | 1 |
| CHU Brest | Brest | France | 37 |
| CHU Nantes | Nantes | France | 86 |
| CHU Nice | Nice | France | 34 |
| CHU Nîmes | Nîmes | France | 12 |
| Gustave Roussy | Villejuif | France | 47 |
| Hôpital de la Milétrie, CHU | Poitiers | France | 1 |
| Hôpital Saint-Louis | Paris | France | 16 |
| Imperial College London / Hammersmith Hospital | London | United Kingdom | 1 |
| Institut Paoli-Calmettes | Marseille | France | 23 |
| Royal Hallamshire Hospital | Sheffield | United Kingdom | 4 |
| Sarah Cannon Research Institute | London | United Kingdom | 4 |
| University Hospital of Wales | Cardiff | United Kingdom | 25 |
| University of Southampton Hospital | Southampton | United Kingdom | 1 |